Comment on "Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)". [PDF]
Int Forum Allergy RhinolMalik MMUD.
europepmc +1 more source
Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis. [PDF]
Adv TherHan JK +9 more
europepmc +1 more source
Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network report. [PDF]
Open Respir ArchPlaza V +4 more
europepmc +1 more source
Evaluating the Potential Infectious Risk Profile of Biologics in Chronic Rhinosinusitis With Nasal Polyposis. [PDF]
Int Forum Allergy RhinolFieux M, Gevaert P, Sowerby LJ.
europepmc +1 more source
Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient
Journal of Investigational Allergy and Clinical ImmunologyS, Bautista-Villanueva +3 more
openaire +2 more sources
Real-World Phenotypic Profiles and Longitudinal Lung Function Outcomes in Severe Asthma Treated with Biologic Therapies. [PDF]
J Pers MedKotsiou OS +3 more
europepmc +1 more source
High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting. [PDF]
World Allergy Organ JCerda Reyes S +2 more
europepmc +1 more source
Biologic therapies targeting type 2 inflammation in NSAID-exacerbated respiratory disease. [PDF]
Front ImmunolSzatkowski P +3 more
europepmc +1 more source